BioCentury
ARTICLE | Company News

Management tracks

December 23, 2016 12:24 AM UTC

As part of a restructuring, fertility company OvaScience Inc. (NASDAQ:OVAS) said President and CEO Harald Stock and COO Paul Chapman will leave the company. OvaScience is also reducing headcount by about 30%, slowing commercial expansion and reassessing the development of its Augment mitochondrial technique for in vitro fertilization. Executive chair and co-founder Michelle Dipp will lead the company while it seeks a new CEO.

Synthetic biology and microbiome company Synlogic Inc. (Cambridge, Mass.) named Samantha Truex COO and head of corporate development. She was CBO at Padlock Therapeutics Inc., which Bristol-Myers Squibb Co. (NYSE:BMY) acquired...